Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?

Journal of Clinical Oncology

Volumn 17, Issue 6, 1999, Pages 1720-1726

  Reynolds, Carol ^a   Mick, Rosemarie ^a   Donohue, John H ^a   Grant, Clive S ^a   Farley, David R ^a   Callans, Linda S ^a   Orel, Susan G ^a   Keeney, Gary L ^a   Lawton, Thomas J ^a   Czerniecki, Brian J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0033039307     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.6.1720     Document Type: Article

References (37)

1. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994
2. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997
3. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 339:941-946, 1998
4. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996
5. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997
6. Czerniecki B, Scheff A, Callans L, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer. Cancer 85:1098-1103, 1999
7. Borgstein PJ, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998
8. Alex JC, Krag DN: The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 5:33-41, 1996
9. Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection. J Surg Oncol 62:75-77, 1996
10. Barnwell JM, Arredondo MA, Kollmorgen D, et al: Sentinel node biopsy in breast cancer. Ann Surg Oncol 5:126-130, 1998
11. Beahrs O, Henson D, Hutter R, et al: Handbook for Staging of Cancer (ed 4). Philadelphia, PA, JB Lippincott, 1993
12. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, NY, McGraw-Hill, 1956
13. Mehta C, Patel N: A network algorithm for performing Fisher's Exact Test in R × C Contingency Tables. J Am Stat Assoc 78:427-434, 1983
14. Cox DR: The Analysis of Binary Data. London, United Kingdom, Methuen & Co, 1970
15. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989
16. Cady B, Stone MD, Schuler JG, et al: The new era in breast cancer: Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301-308, 1996
17. Danforth DN Jr, Findlay PA, McDonald HD: Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 4:655-662, 1986
18. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinancy of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772, 1981
19. Mustafa IA, Cole B, Wanebo HJ, et al: The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 132:384-391, 1997
20. Offodile R, Hoh C, Barsky SH, et al: Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 82:1704-1708, 1998
21. Galimberti V, Zurrida S, Zucali P, et al: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? The Breast 7:8-10, 1998
22. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995
23. Visser TJ, Haan M, Keidan R, et al: T1a and T1b breast cancer: A twelve-year experience. Am Surg 63:621-626, 1997
24. Barth A, Craig PH, Silverstein MJ: Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79:1918-1922, 1997
25. Port ER, Tan LK, Borgen PI, et al: Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol 5:23-27, 1998
26. Giuliano AE, Barth AM, Spivack B, et al: Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183:185-189, 1996
27. Huvos AG, Hutter RV, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173:44-46, 1971
28. Fisher ER, Palekar A, Rockette H, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): V. Significance of axillary nodal micro-and macrometastases. Cancer 42:2032-2038, 1978
29. Fisher ER, Swamidoss S, Lee CH, et al: Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 42:2025-2031, 1978
30. Pickren J: Significance of occult metastases: A study of breast cancer. Cancer 42:2025-2031, 1961
31. Trojani M, de Mascarel I, Bonichon F, et al: Micrometastases to axillary lymph nodes from carcinoma of the breast: Detection by immunohistochemistry and prognostic significance. Br J Cancer 55:303-306, 1987
32. Sedmak D, Meineke T, Knechtges D, et al: Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 2:516-520, 1989
33. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568, 1990
34. de Mascarel I, Bonichon F, Coindre J, et al: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 66:523-527, 1992
35. Rosen PP, Saigo PE, Braun DW, et al: Axillary micro- and macrometastases in breast cancer: Prognostic significance of tumor size. Ann Surg 194:585-591, 1981
36. McGuckin MA, Cummings MC, Walsh MD, et al: Occult axillary node metastases in breast cancer: Their detection and prognostic significance. Br J Surg 73:88-95, 1996
37. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459-463, 1993